Schisandrin b preparation
AssigneeThe Hong Kong University of Science and Technology
InventorKam Ming Ko
Life of this patent
Estimating the term…
Abstract
The present invention provides a composition (e.g., a pharmaceutical composition) for reducing aging-related mitochondrial antioxidant status changes in a subject, wherein the composition comprises Schisandrin B. The present invention further provides a composition (e.g., a pharmaceutical composition) for reducing ischemia-reperfusion injury in an aging subject, wherein the composition comprises Schisandrin B. Also provided are methods for reducing aging-related mitochondrial antioxidant status changes and/or for reducing ischemia-reperfusion injury in an aging subject using the same.
Claims18
A composition comprising a Schisandrin B preparation, wherein the Schisandrin B is isolated (−) Schisandrin B.
A composition comprising a Schisandrin B preparation, wherein the Schisandrin B is isolated (−) Schisandrin B and said Schisandrin B preparation is a solvent based preparation.
Dependencies are inferred from the claim text.